1. Home
  2. PLD vs GSK Comparison

PLD vs GSK Comparison

Compare PLD & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prologis Inc.

PLD

Prologis Inc.

HOLD

Current Price

$131.46

Market Cap

124.9B

Sector

Real Estate

ML Signal

HOLD

Logo GSK plc (Each representing two)

GSK

GSK plc (Each representing two)

HOLD

Current Price

$53.47

Market Cap

96.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLD
GSK
Founded
1983
1715
Country
United States
United Kingdom
Employees
2802
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.9B
96.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PLD
GSK
Price
$131.46
$53.47
Analyst Decision
Buy
Buy
Analyst Count
18
2
Target Price
$135.29
N/A
AVG Volume (30 Days)
2.7M
4.9M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.25%
3.23%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.41
$6.81
Revenue Next Year
$5.88
$4.74
P/E Ratio
$39.25
$32.75
Revenue Growth
N/A
N/A
52 Week Low
$85.35
$32.38
52 Week High
$143.95
$61.70

Technical Indicators

Market Signals
Indicator
PLD
GSK
Relative Strength Index (RSI) 38.36 37.71
Support Level $126.25 $47.89
Resistance Level $134.94 $60.37
Average True Range (ATR) 2.68 0.93
MACD -1.33 -0.78
Stochastic Oscillator 12.40 1.31

Price Performance

Historical Comparison
PLD
GSK

About PLD Prologis Inc.

Prologis was formed by the 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.3 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party assets under management. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Share on Social Networks: